WebSite Logo
  • Content
  • Similar Resources
  • Metadata
  • Cite This
  • Language
    অসমীয়া বাংলা भोजपुरी डोगरी English ગુજરાતી हिंदी ಕನ್ನಡ
    Khasi कोंकणी मैथिली മലയാളം ꯃꯤꯇꯩ ꯂꯣꯟ मराठी Mizo नेपाली
    ଓଡ଼ିଆ ਪੰਜਾਬੀ संस्कृत ᱥᱟᱱᱛᱟᱲᱤ सिन्धी தமிழ் తెలుగు اردو
  • Log-in
  • Fullscreen
Log-in
Do not have an account? Register Now
Forgot your password? Account recovery
  1. World Journal of Clinical Oncology
  2. Year: 2012, Volume: 3
  3. Year: 2012, Volume: 3, Issue: 7
  4. Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies
Loading...

Please wait, while we are loading the content...

Year: 2016, Volume: 7
Year: 2015, Volume: 6
Year: 2014, Volume: 5
Year: 2013, Volume: 5
Year: 2013, Volume: 4
Year: 2012, Volume: 3
Year: 2012, Volume: 3, Issue: 12
Year: 2012, Volume: 3, Issue: 11
Year: 2012, Volume: 3, Issue: 10
Year: 2012, Volume: 3, Issue: 9
Year: 2012, Volume: 3, Issue: 8
Year: 2012, Volume: 3, Issue: 7
Inhibition of carbonic anhydrase IX as a novel anticancer mechanism
Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells
Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies
Year: 2012, Volume: 3, Issue: 6
Year: 2012, Volume: 3, Issue: 5
Year: 2012, Volume: 3, Issue: 4
Year: 2012, Volume: 3, Issue: 3
Year: 2012, Volume: 3, Issue: 2
Year: 2012, Volume: 3, Issue: 1
Year: 2011, Volume: 2
Year: 2010, Volume: 1

Similar Documents

...
P08: Somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors

Article

...
P12: Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumors

Article

...
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

Article

...
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

Article

...
Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors

Article

...
Radioimmunoassay for octapeptide analogs of somatostatin: measurement of serum levels after administration of long-acting microcapsule formulations.

Article

...
Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors

Article

...
Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report

Article

...
P06.08SYSTEMIC TREATMENT OF MENINGIOMAS: IS THERE A ROLE FOR LONG-ACTING SOMATOSTATIN?

Article

Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies

Content Provider PubMed Central
Author Palmieri, Giovannella Carlo, Buonerba Federico, Piera Formisano, Luigi Nappi, Lucia Lorenzo, Giuseppe Di Marino, Mirella Damiano, Vincenzo
Copyright Year 2012
Abstract Although thymic epithelial tumors (TETs) are rare in the general population, they represent the most frequently diagnosed primary malignant tumor of the anterior mediastinum. Unlike localized disease, metastatic disease is invariably fatal. While several chemotherapy agents have proven to be effective in TETs, somatostatin analogs are the only targeted agents with an established role in this disease. Everolimus is an mTOR inhibitor with multiple application in oncology. In this report, we show for the first time that everolimus was effective in two heavily pretreated patients with advanced TETs, with a progression-free survival longer than 1 year and minimal toxicity.
Related Links http://dx.doi.org/10.5306/wjco.v3.i7.111
Starting Page 111
File Format PDF
ISSN 22184333
e-ISSN 22184333
Journal World Journal of Clinical Oncology
Issue Number 7
Volume Number 3
Language English
Publisher Baishideng Publishing Group Co., Limited
Publisher Date 2012-01-01
Access Restriction Open
Rights Holder Baishideng Publishing Group Co., Limited
Subject Keyword Research in Higher Education
Content Type Text
Resource Type Article
Subject Oncology
  • About
  • Disclaimer
  • Feedback
  • Sponsor
  • Contact
About National Digital Library of India (NDLI)
NDLI logo

National Digital Library of India (NDLI) is a virtual repository of learning resources which is not just a repository with search/browse facilities but provides a host of services for the learner community. It is sponsored and mentored by Ministry of Education, Government of India, through its National Mission on Education through Information and Communication Technology (NMEICT). Filtered and federated searching is employed to facilitate focused searching so that learners can find the right resource with least effort and in minimum time. NDLI provides user group-specific services such as Examination Preparatory for School and College students and job aspirants. Services for Researchers and general learners are also provided. NDLI is designed to hold content of any language and provides interface support for 10 most widely used Indian languages. It is built to provide support for all academic levels including researchers and life-long learners, all disciplines, all popular forms of access devices and differently-abled learners. It is designed to enable people to learn and prepare from best practices from all over the world and to facilitate researchers to perform inter-linked exploration from multiple sources. It is developed, operated and maintained from Indian Institute of Technology Kharagpur.

Learn more about this project from here.

Disclaimer

NDLI is a conglomeration of freely available or institutionally contributed or donated or publisher managed contents. Almost all these contents are hosted and accessed from respective sources. The responsibility for authenticity, relevance, completeness, accuracy, reliability and suitability of these contents rests with the respective organization and NDLI has no responsibility or liability for these. Every effort is made to keep the NDLI portal up and running smoothly unless there are some unavoidable technical issues.

Feedback

Sponsor

Ministry of Education, through its National Mission on Education through Information and Communication Technology (NMEICT), has sponsored and funded the National Digital Library of India (NDLI) project.

Contact National Digital Library of India
Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302
See location in the Map
03222 282435
Mail: support@ndl.gov.in
Sl. Authority Responsibilities Communication Details
1 Ministry of Education (GoI),
Department of Higher Education
Sanctioning Authority https://www.education.gov.in/ict-initiatives
2 Indian Institute of Technology Kharagpur Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project https://www.iitkgp.ac.in
3 National Digital Library of India Office, Indian Institute of Technology Kharagpur The administrative and infrastructural headquarters of the project Dr. B. Sutradhar  bsutra@ndl.gov.in
4 Project PI / Joint PI Principal Investigator and Joint Principal Investigators of the project Dr. B. Sutradhar  bsutra@ndl.gov.in
Prof. Saswat Chakrabarti  will be added soon
5 Website/Portal (Helpdesk) Queries regarding NDLI and its services support@ndl.gov.in
6 Contents and Copyright Issues Queries related to content curation and copyright issues content@ndl.gov.in
7 National Digital Library of India Club (NDLI Club) Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach clubsupport@ndl.gov.in
8 Digital Preservation Centre (DPC) Assistance with digitizing and archiving copyright-free printed books dpc@ndl.gov.in
9 IDR Setup or Support Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops idr@ndl.gov.in
Cite this Content
Loading...